CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 156 filers reported holding CASTLE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455,490 | +22.7% | 26,968 | -0.3% | 0.02% | +25.0% |
| Q2 2023 | $371,195 | -26.0% | 27,055 | +22.6% | 0.01% | -29.4% |
| Q1 2023 | $501,408 | -3.5% | 22,069 | 0.0% | 0.02% | -26.1% |
| Q4 2022 | $519,504 | -9.8% | 22,069 | -0.1% | 0.02% | -14.8% |
| Q3 2022 | $576,000 | +18.8% | 22,091 | 0.0% | 0.03% | +22.7% |
| Q2 2022 | $485,000 | -49.7% | 22,091 | +0.8% | 0.02% | -42.1% |
| Q1 2022 | $964,000 | +3.3% | 21,909 | +0.6% | 0.04% | +8.6% |
| Q4 2021 | $933,000 | -35.6% | 21,769 | 0.0% | 0.04% | -39.7% |
| Q3 2021 | $1,448,000 | -9.4% | 21,769 | -0.1% | 0.06% | -14.7% |
| Q2 2021 | $1,598,000 | +16.7% | 21,791 | +9.0% | 0.07% | +4.6% |
| Q1 2021 | $1,369,000 | -18.5% | 20,000 | -20.0% | 0.06% | -28.6% |
| Q4 2020 | $1,679,000 | -17.2% | 25,000 | -36.6% | 0.09% | -27.2% |
| Q3 2020 | $2,028,000 | +169.3% | 39,420 | +97.1% | 0.12% | +155.1% |
| Q2 2020 | $753,000 | – | 20,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |